Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
INW is a premier contract development and manufacturing organization (CDMO) dedicated to the health and wellness sector. The company offers a comprehensive suite of services, including custom formulation, manufacturing, and packaging for dietary supplements, sports nutrition, and functional foods. With expertise in diverse delivery formats such as powders, capsules, tablets, and liquids, INW supports a wide array of global brands. The organization operates several high-capacity, GMP-certified facilities across the United States and the United Kingdom. Following its acquisition by Cornell Capital, INW has continued to expand its global footprint and technical capabilities through strategic investments and acquisitions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INW Holdings.